39 reports

One unit refers to one Mycobacterium Diagnostic test.

  • Tuberculosis
  • Australasia
  • Demand
  • Market Size
  • Supply

" Despite steady progress in reducing the burden of tuberculosis in recent decades, TB remains a major global health problem and one of the top ## causes of death worldwide, " said Dr.

  • Tuberculosis
  • United Kingdom
  • Market Size
  • DENTSPLY Sirona Inc.
  • Ivoclar Vivadent AG

Globally, nearly ## million cases of tuberculosis are reported annually resulting in approximately ## million premature deaths each year.

  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company

PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PULMONARY TUBERCULOSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018*

  • Anti-Infective
  • Clinical Trial
  • Tuberculosis
  • World
  • Product Initiative

MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN E## COUNTRIES MYCOBACTERIUM TUBERCULOSIS INFECTIONS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* MYCOBACTERIUM TUBERCULOSIS INFECTION

  • Anti-Infective
  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World

The prominent features of this report are - ##.

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World

Steven Reed, IDRI founder and chief scientific officer, said, " Tuberculosis is one of the most widespread, persistent and deadly global health problems.

  • Pathology
  • Pharmaceutical
  • Tuberculosis
  • Vaccine
  • World

GlobalData genedrive plc reported one medical equipment deal in YTD 2018.

  • Tuberculosis
  • APAC
  • United Kingdom
  • United States
  • World

Our system has the potential to drive major advances in rapid diagnosis of immunologically complex conditions such as tuberculosis. "

  • Diagnostics
  • Tuberculosis
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.

" Q## is undergoing intensive phase ## testing and demonstrates excellent results in all studies, including one that is completed by our partner Infectex", - said Dr.

  • Pharmaceutical
  • Tuberculosis
  • South Korea
  • Company
  • Qurient Co., Ltd.

TUBERCULOSIS COMPLEX SPECIATION TEST.

  • Molecular Diagnostic
  • Tuberculosis
  • United States
  • Company Financials
  • QIAGEN N.V.

One of these preclinical compounds NITD##, blocks MmpL##, a protein essential for the TB bacterium' s survival.

  • Pathology
  • Tuberculosis
  • World
  • Company
  • TB Drug Development, Inc.

This agreement enables Janssen Pharma and FIND to accelerate access to tuberculosis (TB) diagnosis, treatment and care.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World

The study was conducted by researchers from Great Basin and the Public Health Research Institute Tuberculosis Center at the University of Medicine and Dentistry of New Jersey.

  • Infectious Disease
  • Tuberculosis
  • Japan
  • United States
  • GlobalData's company

SQ## could replace one or more of the current TB drugs, simplify therapy, and shorten current treatment time.

  • Tuberculosis
  • Russia
  • United States
  • World
  • Deals & Alliance

" Tuberculosis is a global public health threat, particularly with multi-drug resistant TB strains on the rise, " said GNA Biosolutions Managing Director Lars Ullerich.

  • Antibiotic Resistance
  • In Vitro Diagnostics
  • Tuberculosis
  • Company
  • Product Initiative

Promising results in early clinical studies have been seen in tuberculosis and cystic fibrosis.

  • Pathology
  • Tuberculosis
  • United States
  • Product Initiative
  • Avisa Pharma Inc.

Our system has the potential to drive major advances in rapid diagnosis of immunologically complex conditions such as tuberculosis. "

  • Diagnostics
  • Tuberculosis
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.

The company discovers and validates novel biomarkers for tuberculosis.

  • Diagnostics
  • Tuberculosis
  • Australia
  • Product Initiative
  • Tyrian Diagnostics Limited

Tuberculosis ## Viral Infections ## Human Papilloma Virus Infection ## John Cunningham Virus Infection ## Leishmaniasis ## Liver Cancer ## Lung Cancer ## Lyme Disease ## Malaria ## Melanoma ## Pancreatic Cancer

  • DNA
  • Tuberculosis
  • United States
  • Company
  • Trovagene, Inc.

It' s estimated that up to one-third of the world' s population is infected with M. tuberculosis, the bacterium that causes TB.

  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United States
  • Company

Aeras Global TB Vaccine Foundation Inc(Aeras) is a nonprofit biotechnology organization that develops tuberculosis (TB) vaccines.

  • Pathology
  • Tuberculosis
  • China
  • Corporate Finance
  • GlobalData's company

This system will help us speed up the process of finding treatments and vaccines for human tuberculosis, an infection that kills ##. ## million people per year. "

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United Kingdom

The study was conducted by researchers from Great Basin and the Public Health Research Institute Tuberculosis Center at the University of Medicine and Dentistry of New Jersey.

  • Infectious Disease
  • Tuberculosis
  • Japan
  • United States
  • GlobalData's company

Tuberculosis ## Type I Diabetes Mellitus ## Chlamydia Trachomatis Infection ## Hepatitis C Infection ## Human Immunodeficiency Virus Infection ## Human Immunodeficiency Virus Type ## Infection ## Influenza A Virus Infection ## Liver Can

  • Medical Device
  • Tuberculosis
  • United States
  • Company
  • Product Initiative

Revenue for the first quarter of 2018 was $##. ## million, representing a ##% decrease from first quarter 2017 revenue of $##. ## million.

  • Tuberculosis
  • United States
  • Company
  • Company Financials
  • Market Size

" Despite steady progress in reducing the burden of tuberculosis in recent decades, TB remains a major global health problem and one of the top ## causes of death worldwide, " said Dr.

  • Infectious Disease
  • Tuberculosis
  • United States
  • World
  • Market Size